Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells

Journal of Neurochemistry
Borja GuerraRaquel Marin

Abstract

Rapid oestrogen neuroprotection against beta-amyloid peptide (Abeta)-induced toxicity, a main feature of Alzheimer's disease, may be partially initiated at the plasma membrane. However, the mechanism by which this oestrogen effect occurs is unknown. In a septal murine cell line (SN56), we observed that short exposures to either 17beta-oestradiol (E2) or membrane impermeant E2 bound to horseradish peroxidase (E-HRP) induced a biphasic stimulation of extracellular-signal regulated protein kinase (ERK1/2) phosphorylation, with peak inductions detected around 4-8 min in the early phase and a second maximum around 8 h after treatment. ERK1/2 phosphorylation was abolished by ERK1/2 kinase (MEK) inhibitors PD98059 and U0126. Interestingly, PD98059 was also shown to block rapid E2-related prevention of death in cells exposed to Abeta fragment 1-40 (Abeta1-40) for 24 h. In contrast, no neuroprotective effects were obtained when MEK inhibitor was used to selectively abolish the late phosphorylation phase. Furthermore, both ERK1/2 activation and E2-associated protection were blocked by an inhibitor of Raf-1 kinase. Raf-1 may be involved in these effects because oestrogen caused the rapid serine 338 (Ser338) phosphorylation of this protein...Continue Reading

References

Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R E Rydel, L A Greene
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Feb 1, 1994·Current Opinion in Genetics & Development·C J Marshall
May 18, 1999·Frontiers in Neuroendocrinology·C D Toran-AllerandG Sétáló
Mar 4, 2000·Bioorganic & Medicinal Chemistry Letters·K LackeyE R Wood
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·R BiM Baudry
May 19, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·P S Green, J W Simpkins
Sep 22, 2000·The Biochemical Journal·S P DaviesP Cohen
Oct 21, 2000·Progress in Neurobiology·L M Garcia-SeguraL L DonCarlos
Jun 27, 2001·Journal of Neurocytology·P S GreenJ W Simpkins
Jan 18, 2002·Journal of Neurochemistry·H ZhengK Duff
Feb 2, 2002·The Journal of Biological Chemistry·Jeffrey P GreenfieldHuaxi Xu
Jun 21, 2002·Biochemical and Biophysical Research Communications·Zhenguo ZhangRobert X-D Song
Oct 4, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Cordian BeyerEva Küppers
Nov 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Chi-Wai WongBoris J Cheskis
May 22, 2003·Progress in Neurobiology·Phyllis M Wise
Jan 30, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Reymundo DominguezSonsoles de Lacalle

❮ Previous
Next ❯

Citations

Jan 30, 2010·Journal of Vascular Research·Kunju SathishkumarChandra Yallampalli
Feb 7, 2008·Neuro-Signals·Limor RazDarrell W Brann
Jun 23, 2009·European Journal of Pharmacology·Tonia LucaGiuseppina Cantarella
May 20, 2009·Frontiers in Neuroendocrinology·Colin J SaldanhaBradley J Walters
Jan 27, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Raquel MarinLuis M Garcia-Segura
Jun 3, 2008·Molecular and Cellular Endocrinology·Marc MorissetteThérèse Di Paolo
Feb 8, 2008·Neurobiology of Aging·Elena TamagnoMassimo Tabaton
Feb 16, 2008·Toxicology and Applied Pharmacology·Zhiwei LiuZahir A Shaikh
Oct 30, 2007·Hormones and Behavior·América Vanoye-CarloMarco Cerbón
Oct 16, 2007·The Journal of Steroid Biochemistry and Molecular Biology·M MorissetteT Di Paolo
Nov 7, 2006·The Journal of Steroid Biochemistry and Molecular Biology·Ana B RoperoAngel Nadal
Jul 19, 2005·Annals of the New York Academy of Sciences·Carey E GleasonSanjay Asthana
Jun 29, 2007·Journal of Neurochemistry·Alfredo MiñanoJosé Rodríguez-Alvarez
Jan 21, 2006·Molecular and Cellular Endocrinology·Julie JacobRaghava Varman Thampan
Oct 1, 2011·Hormone Molecular Biology and Clinical Investigation·Raquel MarinMario Díaz
Nov 15, 2011·Frontiers in Neuroendocrinology·Erin ScottDarrell Brann
Oct 9, 2016·Aging Clinical and Experimental Research·F GuerrieroG Ricevuti
Jan 28, 2017·British Journal of Pharmacology·Zhi-Feng ZhangQi Wan
Jan 15, 2008·Journal of Neuroscience Research·Nik SaweHeng Zhao
Jul 14, 2005·Journal of Neurochemistry·Thuy-Vi V NguyenChristian J Pike
Nov 19, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Su-Kyoung KimInhee Mook-Jung
Jan 11, 2020·Frontiers in Aging Neuroscience·Jose Luis HerreraRafael Alonso
Mar 9, 2017·Journal of Alzheimer's Disease : JAD·Ce ZhangYuanlin Dong
May 10, 2018·Frontiers in Cellular Neuroscience·Jose L HerreraFrancisco G Wandosell
Nov 13, 2018·Frontiers in Neuroscience·Yuki Fujita, Toshihide Yamashita
Nov 25, 2006·Neuroendocrinology·Luis M Garcia-SeguraPablo Mendez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.